NSEShareholders meeting2d ago · 29 Jul 2026, 07:59 pm
Shareholders meeting
Rainbow Childrens Medicare Limited · RAINBOW
✦ AI SummaryMgmt Change
Rainbow Children's Medicare Limited held its 28th Annual General Meeting on July 29, 2026, through video conference, with 63 members present, including 6 promoters and 57 public shareholders.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Rainbow Childrens Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 29, 2026
Attachments (1)
📄pdf
Download →
RAINBOWUSER_29072026195912_Intimationproceedings.pdf
View document text
Rainbow®
Children's ~ BirthRighf
Hospital ~
- BY RAINBOW HOSPITALS
WOMEN CARE I CHILD CARE I FERTILITY
July 29, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department,
Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers,
Mumbai – 400 051. Dalal Street, Mumbai – 400001.
Symbol: RAINBOW Scrip Code: 543524
Sub: Proceedings of the 28th Annual General Meeting of the Company.
Dear Sir/ Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the 28th
Annual General Meeting ("AGM") of the Company was held today, i.e., Wednesday, July 29,
2026, at 10:00 A.M. (IST) through Video Conference ("VC")/ Other Audio-Visual
Means ("OAVM"), in compliance with the applicable provisions of the Companies Act, 2013
and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and
Exchange Board of India.
The AGM concluded at 11:00 P.M (IST).
In this regard, please find attached proceedings of the AGM as required under Regulation 30
of the SEBI Listing Regulations.
This is for your information and records.
Thanking You,
Yours Faithfully,
For Rainbow Children’s Medicare Limited
Shreya Mitra
Company Secretary and Compliance Officer
Encl.: As above
Rainbow Children's Medicare Limited
Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana
CIN :L85110TG 1998PLC029914
Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana
G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in
OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL
Summary of Proceedings of the 28th Annual General Meeting of
Rainbow Children’s Medicare Limited (“Company”)
The 28th Annual General Meeting (“AGM/ Meeting”) of the Members of the Company was held today
i.e., Wednesday, July 29, 2026 through Video Conferencing/ Other Audio-Visual Means (“VC/ OAVM”) in
compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued
by the Ministry of Corporate Affairs and the Securities and Exchange Board of India in this behalf.
The meeting commenced at 10:00 A.M (IST).
The following Directors and Key Managerial Personnel(s) were present:
Name Designation Location
Dr. Ramesh Kancharla Chairman & Managing Director, Chairman of Business Hyderabad,
Strategy & Investment Committee and Treasury Management India
Committee and Member of Risk Management Committee,
Stakeholders Relationship Committee, CSR & ESG Committee
and TCWG Committee.
Dr. Dinesh Kumar Chirla Whole-Time Director and Member of CSR & ESG Committee. Hyderabad,
India
Dr. Adarsh Kancharla Non - Executive Director and Member of Risk Management Hyderabad,
Committee and CSR & ESG Committee. India
Dr. Anil Dhawan Independent Director, Chairman of CSR & ESG Committee Hyderabad,
and member of Audit Committee, Nomination & Remuneration India
Committee, Stakeholders Relationship Committee and TCWG
Committee.
Mr. Aluri Srinivasa Rao Independent Director, Chairman of Nomination & Hyderabad,
Remuneration Committee and member of Audit Committee, India
Nomination & Remuneration Committee, Stakeholders
Relationship Committee, Risk Management Committee, and
TCWG Committee.
Mr. Santanu Mukherjee Independent Director, Chairman of Audit Committee and Risk Hyderabad,
Management Committee and member of Nomination & India
Remuneration Committee, CSR & ESG Committee, Treasury
Management Committee, Business Strategy & Investment
Committee and TCWG Committee.
Ms. Sundari R. Pisupati Independent Director, Chairperson of Stakeholders Hyderabad,
Relationship Committee and member of Audit Committee, India
Nomination & Remuneration Committee and CSR & ESG
Committee, Business Strategy & Investment Committee and
TCWG Committee.
Mr. Abrarali Dalal Chief Executive Officer and Member of Risk Management Hyderabad,
Committee, Business Strategy & Investment Committee and India
TCWG Committee.
Mr. Vikas Maheshwari Chief Financial Officer and Member of Risk Management Hyderabad,
Committee, Treasury Management Committee and TCWG India
Committee.
Ms. Shreya Mitra Company Secretary & Compliance Officer. Hyderabad,
India
The details of number of Members present in the meeting are as follows:
Promoter & Promoter Group Public Total
6 57 63
The moderator welcomed the Members to the 28th AGM of the Company and gave them the instructions
for joining the meeting through video conference.
Thereafter, Dr. Ramesh Kancharla, Chairman & Managing Director, Dr. Dinesh Kumar Chirla, Whole-time
Director, Dr. Adarsh Kancharla, Non– Executive Director, Dr. Anil Dhawan, Mr. Aluri Srinivasa Rao, Mr.
Santanu Mukherjee, Ms. Sundari R. Pisupati, Independent Directors, Mr. Abrarali Dalal, Chief Executive
Officer, Mr. Vikas Maheshwari, Chief Financial Officer and Ms. Shreya Mitra, Company Secretary &
Compliance Officer introduced themselves to the Members.
Thereafter, the moderator confirmed the presence of the following:
Mr. Chirag C Shah Director, M/s. S.R. Batliboi & Associates LLP, Statutory Auditors of the
Company.
Mr. K.V.S Subramanyam Practicing Company Secretary, Secretarial Auditor of the Company.
Mr. Prabhat Naulakha Associate Director, M/s. Deloitte Touche Tohmatsu India LLP, Internal
Auditors of the Company.
Ms. K.V.N. Lavanya Designated Partner, M/s. Lavanya and Associates LLP, Cost
Accountants, Cost Auditors of the Company.
Thereafter, Ms. Shreya Mitra, Company Secretary & Compliance Officer, welcomed the Members who
were participating in the Meeting through Video Conference and provided the general instructions to the
members regarding participation in the AGM.
She further informed that the Statutory Registers under the Companies Act, 2013 along with the other
documents as mentioned in the AGM Notice are available for inspection by the members and also
confirmed the presence of quorum. Thereafter, she requested Dr. Ramesh Kancharla to chair the meeting.
Dr. Ramesh Kancharla, took the chair and welcomed the members and read out his speech. Dr. Ramesh
Kancharla, further requested Mr. Abrarali Dalal, Chief Executive Officer of the Company, to address the
shareholders of the Company.
The Chairman also informed that the Statutory Auditors’ Report and Secretarial Auditors’ Report for the
Financial Year ended March 31, 2026 did not contain any qualifications, observations or comments on
financial transactions or matters which had adverse effect on the functioning of the Company and
therefore, were not required to be read at the AGM. The notice of the AGM was, then, taken as read, as
the same was already circulated to the Members.
Thereafter, Ms. Shreya Mitra, Company Secretary & Compliance Officer, took up the following items of
business, as per the Notice of AGM:
S. No Details of Resolutions Type of Resolution
(Ordinary/ Special)
ORDINARY BUSINESS
1. To receive, consider and adopt the Audited Standalone Financial Ordinary
statements of the Company for the Financial Year ended March 31,
2026, the reports of the Auditors and Board of Directors thereon and
the Audited Consolidated Financial statements of the Company for the
Financial Year ended March 31, 2026 and the report of the Auditors
thereon.
2. To declare dividend of ₹3.5/- per Equity Share for the Financial Year Ordinary
ended March 31, 2026.
3. To appoint a Director in place of Dr. Adarsh Kancharla (DIN: 08302615), Ordinary
who retires by rotation and being eligible offers himself for re-
appointment.
SPECIAL BUSINESS
4. To ratify the remuneration payable to Cost Auditors for the Financial Ordinary
Year 2026-27.
5. To consider review and approve the re-appointment of Dr. Ramesh Ordinary
Kancharla (DIN: 00212270), Chairman and Managing Director of the
Company.
6. To consider, review and approve the remuneration payable to Dr. Special
Ram
[Showing first 8,000 characters — download PDF for full document]